
Scientific Health Development (SHD) is a venture capital firm founded in 2006 and based in Dallas, TX. The firm invests in early-stage, innovative medical device and medtech companies at the intersection of enhanced patient outcomes, improved economics, and usability.
33% of their portfolio is in Enterprise Software. Their most common stage is series-a (56% of deals). Average disclosed round size is $10.6M (across 9 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $7M | Oct 2025 | |
| Series A | $7M | Apr 2025 | |
| Series B | $26M | Nov 2023 | |
| LLiberate Medical | Series B | $6.2M | Jul 2023 |
| Series B | $10M | Jun 2021 | |
| MMindera Corporation | Series A | $12.6M | May 2021 |
| Unknown | $14.1M | Jan 2017 | |
| Series A | $5.3M | — | |
| SSecondWave | Series A | $7M | — |
Top Co-Investors
Mountain Group Partners2 shared
True Ventures2 shared
University of Minnesota1 shared
Sectoral Asset Management1 shared
Longwood Fund1 shared
Third Point Ventures1 shared
Aperture Venture Partners1 shared
Asahi Kasei1 shared
OrbiMed1 shared
Revelation Partners1 shared
Last updated: 9 September 2026